Author
Susanne Theiß
Heidelberg University
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2022-2026 · peak 3/yrCo-Author Collaboration Network
10 top collaborators · 17 mutual co-author links4 papers
Recent·Most cited
- GeneticsbioRxivPreprint
SMCHD1 is a novel target for gene-activation therapy to treat Prader-Willi Syndrome
Megan Iminitoff, Anna K. Le Fevre, Tamara Cameron…·Marnie E. Blewitt
This study identifies SMCHD1 as a target for gene-activation therapy in Prader-Willi Syndrome by showing its role in repressing the PWS gene cluster and demonstrating gene activation in mouse models.
DOI 10.64898/2026.05.13.725051 - NeurosciencebioRxivPreprint
Multi-omics profiling reveals MAGEL2-driven defects in human corticogenesis shared across Prader-Willi and Schaaf-Yang syndromes.
Jannis Buecking, Baran E. Güler, Michael Eibl…·Magdalena Laugsch
This study identifies MAGEL2-driven defects in human corticogenesis shared between Prader-Willi and Schaaf-Yang syndromes using multi-omics profiling of induced neurons.
1 citation - NeurosciencebioRxivPreprint
A truncating mutation of Magel2 in the rat modelled for the study of Schaaf-Yang and Prader-Willi syndromes alters select behavioral and physiological outcomes
Derek L. Reznik, Mingxiao V. Yang, Pedro Albelda de la Haza…·Rodney C. Samaco
This study generates and characterizes a rat model with a truncating Magel2 mutation, revealing altered behavioral and physiological traits consistent with human neurodevelopmental disorders.
DOI 10.1101/2022.08.09.503377